Clarivate Plc

Clarivate Plc provides information services and analytics to customers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Its offerings include scientific and academic research solutions such as the Web of Science Research Intelligence platform, an AI-native tool for research insights. It also provides ProQuest solutions for accessing multidisciplinary curated content including databases, dissertations, news, and primary sources, as well as library software like Alma, Vega, and Polaris. In intellectual property, Clarivate offers Derwent Innovation, an AI-powered patent search tool, Derwent World Patents Index, CompuMark for trademark search and watch, IP Recordals managed services, RiskMark for trademark risk evaluation, and IPfolio management platform. For life sciences and healthcare, it provides Cortellis for market assessment and regulatory compliance, Regulatory Intelligence platform, commercial solutions, and Medtech solutions. The company serves academic institutions, government agencies, and life sciences and pharmaceutical companies.

Clarivate Plc is listed on the New York Stock Exchange (NYSE) under the ticker symbol CLVT. The company's shares trade in US Dollars (USD). Being listed on a major US exchange provides liquidity and access to a broad investor base. The choice of USD as the trading currency aligns with the global nature of its business, as Clarivate generates revenue in multiple currencies but reports its financial results in US dollars.

Clarivate Plc operates in the Technology sector and is classified under the Information Technology Services industry. This classification reflects the company's focus on providing technology-driven information and analytics solutions to various sectors, including academia, government, intellectual property, and life sciences. As an information services provider, Clarivate leverages advanced technologies such as artificial intelligence to deliver insights and data to its clients, helping them make informed decisions in research, innovation, and regulatory compliance.

Clarivate Plc is headquartered in London, United Kingdom, and serves customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company's global presence allows it to support academic institutions, government agencies, and life sciences and pharmaceutical companies worldwide. Its geographic reach is supported by a portfolio of products tailored to regional needs, such as library management systems for public libraries and patent services for intellectual property professionals. The company's founding dates back to 1864, giving it a long history of serving information needs across multiple continents.

Clarivate Plc generates revenue through subscription-based and transactional services across its three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. In the Academia & Government segment, revenue comes from providing access to research databases like Web of Science and ProQuest, as well as library management software such as Alma and Polaris. The Intellectual Property segment earns through patent search and analytics tools like Derwent Innovation, trademark services including CompuMark and RiskMark, and IP management platforms like IPfolio. The Life Sciences & Healthcare segment generates revenue from solutions like Cortellis for drug development decisions, Regulatory Intelligence for compliance, and Medtech solutions. The company's business model relies on recurring subscriptions, annual contracts, and usage-based fees, providing a steady income stream from a diverse client base.